Image-guided PO 2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats

Journal of Nuclear Medicine

Volumn 53, Issue 10, 2012, Pages 1608-1615

  Bartlett, Rachel M ^a   Beattie, Bradley J ^a   Naryanan, Manoj ^b   Georgi, Jens Christoph ^c   Chen, Qing ^a   Carlin, Sean D ^a   Roble, Gordon ^a   Zanzonico, Pat B ^a   Gonen, Mithat ^a   O'Donoghue, Joseph ^a   Fischer, Alexander ^c   Humm, John L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b PHILIPS RESEARCH LABORATORIES   (Netherlands)

^c PHILIPS RESEARCH LABORATORIES   (Germany)

Author keywords

18F fluoromisonidazole; 18F FMISO; Hypoxia; Kinetic modeling; OxyLite probe; Parametric images

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; OXYGEN; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; DIAGNOSTIC AGENT; DRUG DERIVATIVE; MISONIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG UPTAKE; FLUORESCENCE IMAGING; HYPOXIA; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; MOLECULAR PROBE; NONHUMAN; OXYGEN TENSION; OXYGEN TISSUE LEVEL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; ANIMAL; BIOLOGICAL MODEL; CELL HYPOXIA; KINETICS; METABOLISM; PATHOLOGY; PRESSURE; SCINTISCANNING; SKIN TUMOR;

ANIMALS; CELL HYPOXIA; KINETICS; MALE; MISONIDAZOLE; MODELS, BIOLOGICAL; OXYGEN; POSITRON-EMISSION TOMOGRAPHY; PRESSURE; RATS; SKIN NEOPLASMS;

EID: 84867073893     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.103523     Document Type: Article

References (38)

1. Brizel DM, Scully SP, Harrelson JM, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 1996;56:941-943. (Pubitemid 26065381)
2. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996;56:4509-4515. (Pubitemid 26330463)
3. Mottram JC. A factor of importance in the radio-sensitivity of tumours. Br J Radiol. 1936;9:606-614.
4. Teicher BA, Holden SA, al-Achi A, Herman TS. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma. Cancer Res. 1990;50:3339-3344. (Pubitemid 20190142)
5. Nozue M, Lee I, Yuan F, et al. Interlaboratory variation in oxygen tension measurement by Eppendorf "Histograph" and comparison with hypoxic marker. J Surg Oncol. 1997;66:30-38. (Pubitemid 27381476)
6. Olive PL, Banath JP, Aquino-Parsons C. Measuring hypoxia in solid tumours: is there a gold standard? Acta Oncol. 2001;40:917-923. (Pubitemid 34098477)
7. Koh WJ, Rasey JS, Evans ML, et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys. 1992;22:199-212.
8. Valk PE, Mathis CA, Prados MD, Gilbert JC, Budinger TF. Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. J Nucl Med. 1992;33:2133-2137.
9. Chapman JD, Lee J, Meeker BE. Adduct formation by 2-nitromidazole drugs in mammalian cells: optimization of markers for tissue oxygenation. In: Adams GE, Breccia A, Fielden EM, Wardman P, eds. Selective Activation of Drugs by Redox Processes. New York, NY: Springer; 1991:313-323.
10. 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode. Acta Oncol. 2010;49:934-940.
11. Casciari JJ, Graham MM, Rasey JS. A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data. Med Phys. 1995;22:1127-1139.
12. Kelly CJ, Brady M. A model to simulate tumour oxygenation and dynamic 18F-Fmiso PET data. Phys Med Biol. 2006;51:5859-5873. (Pubitemid 46217672)
13. 18F]-Fmiso PET data to analyse tumour hypoxia. Phys Med Biol. 2005;50:2209-2224.
14. Wang W, Georgi JC, Nehmeh SA, et al. Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging. Phys Med Biol. 2009;54:3083-3099.
15. Zanzonico P, Campa J, Polycarpe-Holman D, et al. Animal-specific positioning molds for registration of repeat imaging studies: comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumors. Nucl Med Biol. 2006;33:65-70. (Pubitemid 43184079)
16. Grierson JR, Link JM, Mathis CA, Rasey JS, Krohn KA. A radiosynthesis of fluorine-18 fluoromisonidazole. J Nucl Med. 1989;30:343-350. (Pubitemid 19077324)
17. Kazanzides P, Chang J, Iordachita I, Li J, Ling CC, Fichtinger G. Design and validation of an image-guided robot for small animal research. Med Image Comput Comput Assist Interv. 2006;9:50-57. (Pubitemid 44609089)
18. Kazanzides P, Chang J, Iordachita I, Li J, Ling CC, Fichtinger G. Development of an image-guided robot for small animal research. Comput Aided Surg. 2007;12:357-365. (Pubitemid 350232916)
19. 18F-FMISO PET-guided intratumoral pO2 measurements. Med Phys. 2009;36:5301-5309.
20. Carlin S, Pugachev A, Sun X, et al. In vivo characterization of a reporter gene system for imaging hypoxia-induced gene expression. Nucl Med Biol. 2009;36:821-831.
21. Kessler RM, Ellis JR Jr, Eden M. Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr. 1984;8:514-522. (Pubitemid 14122897)
22. Bao JY. Rat tail: a useful model for microvascular training. Microsurgery. 1995;16:122-125.
23. Blain B, Zhang F, Jones M, et al. Vascular grafts in the rat model: an anatomic study. Microsurgery. 2001;21:80-83.
24. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32-35.
25. Griffiths JR, Robinson SP. The OxyLite: a fibre-optic oxygen sensor. Br J Radiol. 1999;72:627-630. (Pubitemid 29355605)
26. Hall EJ, Giaccia AJ. Radiobiology for the Radiologist. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:85-103.
27. Sørensen M, Horsman MR, Cumming P, Munk OL, Keiding S. Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors. Int J Radiat Oncol Biol Phys. 2005;62:854-861. (Pubitemid 40779779)
28. Krohn KA, Link JM, Mason RP. Molecular imaging of hypoxia. J Nucl Med. 2008;49(suppl 2):129S-148S. (Pubitemid 351948041)
29. Elas M, Ahn KH, Parasca A, et al. Electron paramagnetic resonance oxygen images correlate spatially and quantitatively with Oxylite oxygen measurements. Clin Cancer Res. 2006;12:4209-4217.
30. Hicks RJ, Rischin D, Fisher R, Binns D, Scott AM, Peters LJ. Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent. Eur J Nucl Med Mol Imaging. 2005;32:1384-1391. (Pubitemid 41746841)
31. Lin Z, Mechalakos J, Nehmeh S, et al. The influence of changes in tumor hypoxia on dose-painting treatment plans based on F-18-FMISO positron emission tomography. Int J Radiat Oncol Biol Phys. 2008;70:1219-1228. (Pubitemid 351296122)
32. Thorwarth D, Eschmann SM, Scheiderbauer J, Paulsen F, Alber M. Kinetic analysis of dynamic 18 F- fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer. 2005;5:152-161.
33. 18F FMISO correlates with radiation therapy outcome in head-and-neck cancer patients. Radiother Oncol. 2006;80:151-156.
34. 2O) and power Doppler ultrasonography in feline fibrosarcomas*. Vet Comp Oncol. 2005;3:211-221.
35. Rajendran JG, Wilson DC, Conrad EU, et al. F-18 FMISO and F-18 FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging. 2003;30:695-704. (Pubitemid 36612952)
36. Roels S, Slagmolen P, Nuyts J, et al. Biological image-guided radiotherapy in rectal cancer: is there a role for FMISO or FLT, next to FDG? Acta Oncol. 2008;47:1237-1248.
37. 18F- fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors. J Nucl Med. 2011;52:437-444.
38. 18F FMISO-PET in HNSCC. When is the contrast best? Nuklearmedizin. 2011;50:22-27.